Europe Sleep Apnea Devices Market

Philips (Netherlands) and ResMed (US) are the leading key players in the Europe Sleep Apnea Devices Market

The Europe sleep apnea devices market was valued at around USD 1.88 billion in 2026 and is expected to reach around USD 2.69 billion in 2031, growing at a CAGR of 7.4%. The market has experienced impressive growth due to rapid advancements in the diagnosis and treatment of sleep disorders. Innovations in CPAP devices have significantly influenced the sleep apnea devices market, helping maintain stability despite the rising prevalence of sleep disorders. Additionally, the growing need for patient-centric devices has further shaped the sleep apnea devices market in Europe.

The leading players in the Europe sleep apnea devices market include Philips (Netherlands), Löwenstein Medical SE & Co. KG (Germany), Tomed GmbH (Germany), LivaNova PLC (UK), ResMed (US), Fisher & Paykel Healthcare (New Zealand), SomnoMed (Australia), Inspire Medical Systems (Canada), Drive DeVilbiss International (US), BMC (China), BRAEBON Medical Corporation (Canada), Panthera Dental (Canada), Myerson LLC (US), ProSomnus Sleep Technologies (US), Nidek Medical India (India), Invacare Holdings Corporation (US), MPowrx Health & Wellness Products Inc. (Canada), Nihon Kohden Corporation (Japan), SICAT GmbH & Co. KG (Germany), Vivos Therapeutics, Inc. (US), Airway Management (US), and Apnea Sciences (US). These companies are actively expanding their presence in the Europe sleep apnea devices market through a variety of strategies, including the development of advanced diagnostic and therapeutic devices, strategic collaborations and partnerships, agreements, mergers, and acquisitions, as well as geographical expansion.

To know about the assumptions considered for the study download the pdf brochure

ResMed is recognized as a leader in the sleep apnea device market in Europe. The company has successfully leveraged its experience in healthcare technology and medical devices to develop sleep apnea devices with accurate diagnostic and therapeutic capabilities. The company has expanded its portfolio of sleep apnea devices, including positive airway pressure devices and comfortable facial interface devices, to deliver optimal treatment to patients in Europe.

Koninklijke Philips N.V. holds a significant share of the European sleep apnea device market. Focused on sleep health, Philips has gained a competitive edge in respiratory care and health monitoring solutions. Philips is well known for innovative development and patient-friendly devices that improve the quality of life for patients with sleep apnea. In recent times, through strategic partnerships and collaborations with key healthcare providers, Philips has strengthened its presence in Europe; it aims to increase awareness of sleep disorders and promote the more universal adoption of effective diagnostic and therapeutic solutions across the region.

Market Ranking

The key players in this market in Europe are recognized for offering a broad range of products and implementing relentless technology upgrades. These key players include Philips, a company from the Netherlands; ResMed, a US-based company; Fisher & Paykel Healthcare, a New Zealand-based company; and SomnoMed, a company from Australia. ResMed and Fisher & Paykel Healthcare are recognized for offering technologically advanced diagnostic and therapeutic solutions applicable in both home- and clinical-based environments. Philips and SomnoMed also maintain a competitive advantage in this market due to the integrated sleep diagnostic solutions they offer, enabling fast and precise results that support timely clinical decisions in critical situations and daily practice. Other key players are contributing to this market by providing innovative solutions to improve workflow efficiency and quality of care.

Related Reports:

Europe Sleep Apnea Devices Market by Product [Therapeutic {PAP (CPAP, APAP, BPAP), Oral Appliances, Masks}, Diagnostic {PSG, Home Sleep Testing, Oximeter}], Age, Gender, End User [Sleep Clinics, Hospitals, Home Care Settings]–Forecast To 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com

 

Europe Sleep Apnea Devices Market Size,  Share & Growth Report
Report Code
MD 10281
RI Published ON
2/2/2026
Choose License Type
BUY NOW
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
X
GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

SEND ME A FREE SAMPLE
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2026 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status